PKYASXPathkey.ai Ltd

PKY price activity

Last Price

Change (24hr)

AUD (%)

Volume

Volume (4w avg)

Previous Close

N/A

Last Trade

PKY price performance

13.33%

-42.37%

112.5%

YTD

78.95%

PKY price fundamentals

N/A

Shares Issued

N/A

Earnings Per Share (EPS)

N/A

Dividends Per Share (DPS)

N/A

P/E Ratio

Price market cap

Market cap

N/A

AU-ASX rank

N/A

Sector Rank

N/A

PKY details

View company website

View AU-ASX Official Page

PKY Market Signals

More ways to discover

Browse Australia news Discover ASX signals Browse all ASX stocks

Pathkey.ai Ltd (AU-ASX: PKY)

Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The company serves biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.

Price: A$0.03

Sector: Healthcare — Health Information Services